Top Markets
Coin of the day
American Bio Medica Corporation American Bio Medica Corporation

American Bio Medica Corporation

ABMC
Classifica tra le azioni #42104
American Bio Medica Corporation (ABMC) specializes in the development and... American Bio Medica Corporation (ABMC) specializes in the development and distribution of lateral flow immunoassay tests, primarily designed for the rapid detection of drugs in both urine and oral fluid samples. Their extensive range of urine-based drug screening solutions includes the Rapid Drug Screen, capable of identifying between 2 and 10 substances; the RDS InCup, a convenient testing cup detecting 1 to 12 drugs; Rapid TOX, a cassette-based test for 1 to 10 drugs; and the Rapid TOX Cup II, another cup format that screens for 1 to 16 different drugs. Each product aims to swiftly determine the presence or absence of illicit substances. Furthermore, ABMC provides OralStat, an oral fluid drug test, available also in private-labeled versions. Beyond its proprietary offerings, the company acts as a distributor for various other products focused on detecting substances of abuse and identifying specific infectious diseases. The company extends its expertise to non-affiliated diagnostic firms, offering contract services that encompass the manufacturing, assembly, and packaging of diagnostic strips. Serving a diverse clientele, ABMC caters to the needs of rehabilitation and drug treatment centers, pain management clinics, general clinical settings, government agencies, and employment/workplace screening programs. Its operations span across the United States, Europe, the Asia Pacific region, and South America. Founded in 1986 as American Micro Media, Inc., the company adopted its current name, American Bio Medica Corporation, in September 1992. Its corporate headquarters are situated in Kinderhook, New York.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2025-07-02
Capitalizzazione di mercato
$4.81K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia American Bio Medica Corporation (ABMC)

Categoria

Ricavi di American Bio Medica Corporation (ABMC)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di American Bio Medica Corporation, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per American Bio Medica Corporation da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
$46.34B -
US
$25.11B -
US
- -
CN
$4.55B -
US
$2.71B -
US